Given that IKK activation enhances Plexin-B1-dependent activation of RhoA, which is known to subsequently increase the promigratory activity of cancer cells and to increase tumour progression [24],[25], the IKK-complex may exert some of its tumour-promoting activity through enhanced plexin signalling. The gene discussed is RHOA; the disease is neoplasm.